Skip to main content

Table 1 Market shares* of insulin pens/cartridges and vials/syringes by country (2002 to 2012)

From: Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand

 

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

BRAZIL ***

           

Pens/cartridges**

26.17

29.46

34.71

32.75

36.05

38.15

40.37

43.59

46.38

36.71

29.91

Analogue

1.82

3.89

8.56

14.43

21.38

26.53

30.11

33.43

36.47

27.73

19.81

Human

24.34

25.57

26.15

18.31

14.67

11.62

10.26

10.16

9.91

8.98

10.10

Vials/syringes**

73.83

70.54

65.29

67.25

63.95

61.85

59.63

56.41

53.62

63.29

70.09

Analogue

2.11

2.78

4.14

5.68

6.55

7.17

7.20

7.60

8.12

5.32

4.22

Animal

24.16

19.73

15.40

14.39

5.88

0.55

0.00

0.00

0.00

0.00

0.00

Human

47.56

48.03

45.75

47.19

51.52

54.12

52.43

48.81

45.50

57.97

65.87

CHINA

           

Pens/cartridges**

43.61

48.41

55.81

62.33

67.69

72.71

77.21

80.14

82.86

84.69

85.66

Analogue

0.00

0.33

0.58

1.31

3.58

8.02

14.20

20.35

25.52

30.23

33.92

Animal

0.00

0.00

0.00

0.00

0.31

0.53

0.67

0.62

0.77

0.92

0.52

Human

43.61

48.07

55.23

61.03

63.80

64.16

62.34

59.17

56.57

53.54

51.21

Vials/syringes **

56.39

51.59

44.19

37.67

32.31

27.29

22.79

19.86

17.14

15.31

14.34

Analogue

0.00

0.00

0.00

0.00

0.00

0.02

0.00

0.00

0.00

0.00

0.03

Animal

39.18

36.64

30.33

24.25

21.61

18.08

15.35

14.34

12.72

11.47

10.46

Human

17.21

14.96

13.86

13.42

10.70

9.19

7.44

5.51

4.42

3.84

3.85

THAILAND HOSPITAL

           

Pens/cartridges**

9.25

11.36

15.92

23.46

31.08

37.30

40.83

47.48

48.26

48.95

51.02

Analogue

0.15

0.23

0.41

1.15

1.98

3.66

4.78

5.84

6.24

6.12

6.66

Human

9.10

11.13

15.52

22.31

29.10

33.63

36.05

41.65

42.02

42.83

44.36

Vials/syringes**

90.75

88.64

84.08

76.54

68.92

62.70

59.17

52.52

51.74

51.05

48.98

Analogue

0.00

0.24

0.81

0.79

0.51

0.44

0.36

0.25

0.23

0.17

0.12

Human

90.75

88.40

83.27

75.75

68.42

62.27

58.81

52.27

51.51

50.88

48.86

THAILAND RETAIL

           

Pens/cartridges **

15.91

17.12

21.40

25.78

30.18

38.99

44.37

45.44

54.21

59.35

62.02

Analogue

0.23

0.50

0.62

1.32

2.75

6.86

10.36

15.01

21.33

24.21

27.43

Human

15.68

16.61

20.78

24.46

27.43

32.13

34.01

30.43

32.88

35.14

34.59

Vials/syringes**

84.09

82.88

78.60

74.22

69.82

61.01

55.63

54.56

45.79

40.65

37.98

Analogue

0.00

0.00

0.00

0.00

0.10

0.86

1.23

1.26

1.22

0.72

0.72

Human

84.09

82.88

78.60

74.22

69.72

60.15

54.40

53.29

44.57

39.93

37.26

  1. *Market share is the percentage of the total market volume based on volume sold in international units per 1000 population.
  2. **Pens/cartridges includes: CARTRIDGES, P-F PENS, CARTRIDGES RET and P-F PENS RET. Vials/syringes includes: VIAL, VIAL SC and VIAL SC RET.
  3. ***Exubera was excluded from the analysis because it is an inhaled insulin thus it does not fit the classification applied; it was used only in Brazil, in the years 2007 and 2008, accounting for only 0.15 and 0.03% of the market share.
Back to article page

Journal of Pharmaceutical Policy and Practice

ISSN: 2052-3211

Contact us